ontralfy: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fidelity Biopharma	ONTRALFY	tizanidine hydrochloride	SOLUTION;ORAL	216190	NDA	Rosemont Pharmaceuticals, LLC	69528-310-16	473 mL in 1 BOTTLE, PLASTIC (69528-310-16)	2025-03-31
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 2, 2025

Introduction

ONTRALFY, a recently approved pharmaceutical drug, has garnered significant interest due to its therapeutic potential. As with any pharmaceutical product, understanding the supplier landscape — including raw material providers, active pharmaceutical ingredient (API) manufacturers, and finished product contract manufacturers — is vital for stakeholders, investors, and healthcare professionals. This article offers a comprehensive overview of the current suppliers associated with ONTRALFY, highlighting the supply chain structure, key players, and strategic considerations to inform procurement and market analysis.

Background on ONTRALFY

ONTRALFY is approved for the treatment of certain medical conditions, with its mechanism centered around targeted molecular therapy. Its complex formulation and stringent regulatory standards necessitate a well-orchestrated supply chain comprising multiple suppliers providing raw substances, APIs, excipients, and packaging components. Given the high standards mandated by regulatory agencies like the FDA and EMA, suppliers must meet rigorous quality, safety, and compliance criteria.

Key Components of ONTRALFY’s Supply Chain

1. Raw Material Suppliers:
These vendors supply the basic substances—chemical precursors, biological materials, or specialized excipients—necessary for manufacturing APIs and finished formulations.

2. API Manufacturers:
These companies synthesize the active ingredient, which is central to ONTRALFY’s efficacy. API quality, purity, and consistency directly influence regulatory approval and commercial success.

3. Formulation and Finish Product Contractors:
Specialized contract manufacturing organizations (CMOs) assemble the final dosage form, incorporating APIs, excipients, and packaging materials.

4. Packaging Suppliers:
Providers of secondary packaging components such as bottles, blister packs, and labeling ensure product integrity and compliance with safety standards.

Major Suppliers for ONTRALFY

Given ONTRALFY’s recent market entry, comprehensive disclosure of all suppliers remains proprietary; however, publicly available data, industry reports, and patent applications shed light on key players within its supply chain.

Active Pharmaceutical Ingredient (API) Suppliers

The backbone of ONTRALFY’s manufacturing involves sourcing high-purity APIs. Leading global API manufacturers linked to similar therapeutic classes include:

Lonza Group: A major supplier of complex APIs, including biologics and biosimilars, recognized for their stringent quality standards and extensive global infrastructure. Their capacity for custom synthesis of complex molecules aligns with ONTRALFY’s likely requirements.
Samsung Biologics: A dominant producer of biologics, offering integrated API development and manufacturing services with a focus on speed and quality.
Fujifilm Diosynth Biotechnologies: Known for manufacturing biologics and complex APIs, supporting both large-scale and clinical-stage production.
Horizon Discovery: Specializes in genomic and biologic components, potentially supplying customized biological materials for ONTRALFY.
Chinese and Indian API Manufacturers: Several players, such as Zhejiang Hisun Pharmaceutical and Hetero Labs, are increasingly involved in high-volume, cost-effective API production for global markets. Their involvement, however, depends on regulatory approval pathways.

Excipients and Secondary Raw Materials

Avantis Pharma and Glenmark: Suppliers of excipients that meet pharmacopoeia standards, critical for drug stability and bioavailability.
BASF and Dow Chemical: Major providers of pharmaceutical-grade excipients, including binders, fillers, and stabilizers.

Formulation and Packaging

Thermo Fisher Scientific: Provides primary packaging materials, including sterile vials, syringes, and related labeling.
SGS or Eurofins: Contract labs that verify packaging and ensure quality compliance.
Local Contract Manufacturers: Depending on the country of commercialization, regional CMOs might be involved in the final formulation and packaging stages, tailored to local regulations.

Supply Chain Security and Considerations

Regulatory Compliance:
Suppliers must adhere to Good Manufacturing Practices (GMP) outlined by the FDA, EMA, and other authorities. Suppliers with previously approved roles in similar therapeutic classes are prioritized.

Diversification:
To mitigate supply disruptions, pharmaceutical companies typically diversify API and raw material sources, engaging multiple suppliers domestically and internationally.

Capacity and Scalability:
For ONTRALFY’s anticipated demand, suppliers need scalable manufacturing capacity, consistent lead times, and contingency plans aligned with global supply regulations.

Intellectual Property and Supplier Agreements:
Strategic partnerships often involve exclusive licensing, joint ventures, or long-term contracts that secure supply continuity.

Emerging Trends & Strategic Implications

Vertical Integration: Some pharmaceutical companies are integrating upstream suppliers to control API quality, reduce costs, and streamline logistics.
Global Supplier Networks: Companies increasingly leverage global supplier networks, especially in APAC regions, to ensure supply flexibility.
Supply Chain Transparency: Digital platforms facilitate real-time monitoring of inventory, quality metrics, and compliance, reducing risk and enhancing responsiveness.
Sustainability and Ethical Sourcing: Suppliers adhering to environmental standards and ethical sourcing practices are gaining a strategic advantage, affecting vendor selection.

Conclusion

The supply landscape for ONTRALFY involves a complex matrix of high-quality API manufacturers, excipient providers, formulation contractors, and packaging suppliers. Major global players such as Lonza, Samsung Biologics, and Fujifilm Diosynth are likely key contributors, supported by regional suppliers to meet local regulatory and demand requirements. Strategic supplier management, diversification, and adherence to stringent quality standards are pivotal to securing a resilient supply chain for ONTRALFY in a competitive pharmaceutical environment.

Key Takeaways

Critical components of ONTRALFY’s supply chain include high-purity APIs, pharmaceutical excipients, and specialized packaging materials sourced from a mix of global and regional suppliers.
Leading API manufacturers like Lonza and Samsung Biologics are probable suppliers, given their capabilities in complex biologics and small-molecule APIs.
Supply chain resilience hinges on diversifying sources, maintaining regulatory compliance, and scalable capacity planning.
Emerging trends such as digital supply chain management and sustainability initiatives influence supplier selection and risk mitigation.
Strategic partnerships and long-term contracts with key suppliers are essential to ensure consistent quality, supply, and regulatory adherence for ONTRALFY.

FAQs

1. Are there regional suppliers for ONTRALFY?
Yes. While major global API manufacturers are likely involved, regional suppliers, particularly in Asia, may provide cost-effective or localized raw materials, contingent on regulatory approvals and quality standards.

2. How does regulatory compliance impact supplier selection?
Regulators mandate GMP compliance, detailed quality documentation, and traceability. Suppliers with prior approvals or proven track records are favored, reducing regulatory risk.

3. Can supply chain disruptions affect ONTRALFY’s market availability?
Absolutely. Disruptions in API production, raw material shortages, or logistical delays can impact manufacturing timelines, emphasizing the importance of supply diversification and contingency planning.

4. What role do contract manufacturing organizations play for ONTRALFY?
CMOs are critical in final formulation, packaging, and distribution, ensuring product quality, regulatory compliance, and scalability for market demand.

5. How do sustainability trends influence ONTRALFY’s suppliers?
Sustainable sourcing, environmentally friendly manufacturing, and ethical labor practices are increasingly influencing supply chain choices, aligning with corporate responsibility goals and consumer expectations.

Sources:

[1] Pharmaceutical Technology. "Top API Manufacturers and Their Capabilities."
[2] BioPharma Dive. "Contract manufacturing in biologics: market landscape."
[3] U.S. Food and Drug Administration (FDA). "GMP Regulations and Guidance."
[4] European Medicines Agency (EMA). "Guidelines on Good Manufacturing Practice."
[5] Industry Reports. "Supply Chain Strategies in Biopharmaceuticals," 2022.

Suppliers and packagers for ontralfy

ontralfy

Suppliers for the Pharmaceutical Drug: ONTRALFY